Synaptogenix announces participation at the h.c. wainwright 23rd annual global investment conference

New york, sept. 10, 2021 /prnewswire/ -- synaptogenix, inc (nasdaq: snpx), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced it will be featured as a presenting company at the h.c.
SNPX Ratings Summary
SNPX Quant Ranking